Yusuke Higuchi, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptor, Insulin | 1 | 2021 | 836 | 0.600 |
Why?
|
Communicable Diseases | 1 | 2023 | 879 | 0.500 |
Why?
|
Collateral Circulation | 1 | 2016 | 287 | 0.490 |
Why?
|
Adipocytes | 1 | 2021 | 1179 | 0.480 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2023 | 1200 | 0.460 |
Why?
|
Fibroblasts | 1 | 2023 | 4084 | 0.430 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2016 | 294 | 0.420 |
Why?
|
Graft Occlusion, Vascular | 1 | 2016 | 556 | 0.410 |
Why?
|
Angioplasty, Balloon | 1 | 2016 | 600 | 0.400 |
Why?
|
Cardiomyopathies | 1 | 2023 | 1940 | 0.390 |
Why?
|
Membrane Proteins | 2 | 2024 | 7851 | 0.310 |
Why?
|
Myocardial Reperfusion Injury | 2 | 2021 | 479 | 0.280 |
Why?
|
Renal Dialysis | 1 | 2016 | 1802 | 0.270 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2024 | 45 | 0.220 |
Why?
|
Cell Transdifferentiation | 1 | 2023 | 185 | 0.210 |
Why?
|
Choline | 1 | 2024 | 513 | 0.210 |
Why?
|
Caveolin 1 | 1 | 2024 | 257 | 0.200 |
Why?
|
Myofibroblasts | 1 | 2023 | 207 | 0.200 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 2286 | 0.200 |
Why?
|
3T3-L1 Cells | 1 | 2021 | 209 | 0.190 |
Why?
|
Hepatitis | 1 | 2023 | 231 | 0.190 |
Why?
|
Protein Engineering | 2 | 2023 | 541 | 0.190 |
Why?
|
Aorta, Abdominal | 1 | 2023 | 623 | 0.180 |
Why?
|
Coronary Stenosis | 2 | 2016 | 818 | 0.170 |
Why?
|
Adipogenesis | 1 | 2021 | 358 | 0.160 |
Why?
|
PPAR gamma | 1 | 2021 | 484 | 0.160 |
Why?
|
Adipose Tissue, White | 1 | 2021 | 365 | 0.160 |
Why?
|
Hydroxybutyrate Dehydrogenase | 1 | 2017 | 7 | 0.150 |
Why?
|
Molecular Dynamics Simulation | 1 | 2021 | 434 | 0.150 |
Why?
|
Cricetinae | 1 | 2021 | 2427 | 0.150 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2015 | 1880 | 0.150 |
Why?
|
Aorta, Thoracic | 1 | 2023 | 1094 | 0.140 |
Why?
|
Ventricular Pressure | 1 | 2017 | 204 | 0.140 |
Why?
|
Lipid Metabolism | 2 | 2023 | 1902 | 0.140 |
Why?
|
Mutation | 1 | 2021 | 29877 | 0.140 |
Why?
|
Crystallography, X-Ray | 1 | 2021 | 1978 | 0.140 |
Why?
|
Fibrosis | 1 | 2023 | 2041 | 0.140 |
Why?
|
Hypothermia, Induced | 1 | 2021 | 758 | 0.130 |
Why?
|
Mitochondria, Heart | 1 | 2017 | 229 | 0.130 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1951 | 0.130 |
Why?
|
Sinus of Valsalva | 1 | 2015 | 60 | 0.120 |
Why?
|
Vascular Surgical Procedures | 1 | 2023 | 1471 | 0.120 |
Why?
|
RNA-Binding Proteins | 1 | 2024 | 1902 | 0.120 |
Why?
|
Mice | 9 | 2024 | 81138 | 0.120 |
Why?
|
Muscle Proteins | 1 | 2019 | 1152 | 0.110 |
Why?
|
Animals | 11 | 2024 | 167838 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2448 | 0.110 |
Why?
|
Hypertension, Pulmonary | 1 | 2024 | 1567 | 0.110 |
Why?
|
Regional Blood Flow | 1 | 2016 | 1490 | 0.100 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2014 | 124 | 0.100 |
Why?
|
Coronary Occlusion | 1 | 2015 | 308 | 0.100 |
Why?
|
Coronary Vessel Anomalies | 1 | 2015 | 316 | 0.100 |
Why?
|
Coronary Artery Disease | 3 | 2016 | 6649 | 0.100 |
Why?
|
Catheters | 1 | 2015 | 426 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2667 | 0.100 |
Why?
|
Coronary Vasospasm | 1 | 2012 | 83 | 0.100 |
Why?
|
Oxidative Stress | 2 | 2024 | 3106 | 0.100 |
Why?
|
Mitochondria | 1 | 2024 | 3600 | 0.090 |
Why?
|
Prednisolone | 1 | 2012 | 328 | 0.090 |
Why?
|
Body Weight | 1 | 2021 | 4608 | 0.090 |
Why?
|
Angiography | 1 | 2016 | 1608 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1738 | 0.090 |
Why?
|
Ventricular Remodeling | 1 | 2017 | 1252 | 0.090 |
Why?
|
Glucose | 1 | 2021 | 4361 | 0.080 |
Why?
|
Signal Transduction | 2 | 2024 | 23362 | 0.080 |
Why?
|
Stents | 3 | 2015 | 3308 | 0.080 |
Why?
|
Protein Binding | 1 | 2021 | 9334 | 0.080 |
Why?
|
RNA, Messenger | 1 | 2023 | 12774 | 0.080 |
Why?
|
Abnormalities, Multiple | 1 | 2015 | 1415 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2021 | 3959 | 0.070 |
Why?
|
Eosinophilia | 1 | 2012 | 560 | 0.070 |
Why?
|
Male | 15 | 2024 | 358719 | 0.070 |
Why?
|
Insulin | 1 | 2021 | 6591 | 0.070 |
Why?
|
Coronary Angiography | 5 | 2016 | 4560 | 0.070 |
Why?
|
Cells, Cultured | 1 | 2021 | 18968 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7380 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18110 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2021 | 11476 | 0.060 |
Why?
|
Coronary Vessels | 1 | 2015 | 3112 | 0.060 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2024 | 158 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 21981 | 0.050 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 1930 | 0.050 |
Why?
|
Digoxin | 1 | 2023 | 247 | 0.050 |
Why?
|
Humans | 17 | 2024 | 759255 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2023 | 58867 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2023 | 3143 | 0.050 |
Why?
|
Macaca fascicularis | 1 | 2023 | 899 | 0.050 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2022 | 361 | 0.040 |
Why?
|
Thermogenesis | 1 | 2024 | 468 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2022 | 616 | 0.040 |
Why?
|
Biological Transport | 1 | 2024 | 2086 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11908 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12896 | 0.040 |
Why?
|
Leg | 1 | 2024 | 1091 | 0.040 |
Why?
|
Equipment Design | 2 | 2015 | 3529 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2024 | 2135 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2024 | 14381 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9194 | 0.030 |
Why?
|
Hepatocytes | 1 | 2023 | 1228 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1805 | 0.030 |
Why?
|
Autophagy | 1 | 2023 | 1336 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2016 | 64879 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2024 | 2007 | 0.030 |
Why?
|
Binding Sites | 1 | 2023 | 6053 | 0.030 |
Why?
|
Aged | 5 | 2024 | 168617 | 0.030 |
Why?
|
Thiazoles | 1 | 2021 | 1501 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2630 | 0.030 |
Why?
|
Bone Marrow | 1 | 2024 | 2918 | 0.030 |
Why?
|
Vascular Patency | 1 | 2016 | 904 | 0.030 |
Why?
|
Heart Failure | 1 | 2017 | 11833 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2014 | 11888 | 0.030 |
Why?
|
Equipment Failure | 1 | 2015 | 577 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3336 | 0.030 |
Why?
|
Angina Pectoris | 1 | 2015 | 970 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3537 | 0.020 |
Why?
|
Electrocardiography | 2 | 2014 | 6400 | 0.020 |
Why?
|
Drug-Eluting Stents | 1 | 2016 | 758 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4390 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6070 | 0.020 |
Why?
|
Middle Aged | 6 | 2024 | 219653 | 0.020 |
Why?
|
Liver | 1 | 2023 | 7514 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6436 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9269 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23694 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9528 | 0.020 |
Why?
|
Radiography | 1 | 2015 | 6964 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5775 | 0.010 |
Why?
|
Tomography, Optical Coherence | 1 | 2016 | 2873 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 12940 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2012 | 2142 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12964 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15815 | 0.010 |
Why?
|
Female | 3 | 2024 | 390240 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40109 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39216 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2015 | 80121 | 0.000 |
Why?
|